Keywords: CRAD; Total Monte Carlo; Uncertainty propagation; PKA spectra; Average PKA energy; NRT-dpa; CRaD; NJOY-2016; SRIM-2013;
مقالات ISI CRAD (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: CRAD; CRAd; Oncolytic adenoviruses; Chemotherapeutic; 5-FU; 5-fluorouracil; Î24; 24 nucleotide deletion in CR2 domain of E1A region; Ad; adenovirus; AFP; α-foetoprotein; ATC; anaplastic thyroid cancer; CPA; cyclophosphamide; CPT-11; irinotecan; CR2; conserved
Keywords: CRAD; LER; land equivalence ratio; ISI; intensification sequence index; MP; maize proportion; WPDM; water productivity for dry matter; WPY; water productivity for grain yield; CWATER; water capture efficiency; CRAD; radiation capture efficiency; WUEDM; water us
A study to compute integrated dpa for neutron and ion irradiation environments using SRIM-2013
Keywords: CRAD; SRIM-2013; PKA spectra; NRT-dpa; Damage energy; SiC; CRaD; ENDF/B-VII.1;
KISS1 tumor suppressor restricts angiogenesis of breast cancer brain metastases and sensitizes them to oncolytic virotherapy in vitro
Keywords: CRAD; Gene therapy; Adenovirus; KISS1 tumor suppressor; Breast cancer metastases; CRAd; conditional replicated adenovirus; LDH; lactate dehydrogenase; BrCa; breast cancer; CMV; human cytomegalovirus;
Mesenchymal stem cells deliver and release conditionally replicative adenovirus depending on hepatic differentiation to eliminate hepatocellular carcinoma cells specifically
Keywords: CRAD; CRAd; microRNA-122; AFP promoter; HUMSC; Hepatic differentiation; Hepatocellular carcinoma;
A phase I clinical trial of Ad5/3-Î24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer
Keywords: CRAD; CRAd; Gene therapy; Infectivity-enhanced adenoviral vectors; Ovarian cancer;
Conditionally replicating adenovirus therapy utilizing bone sialoprotein promoter (Ad-BSP-E1a) in an in vivo study of treating androgen-independent intraosseous prostate cancer
Keywords: CRAD; CRAd; BSP; Oncolysis; Prostate cancer; Gene therapy
Combination with low-dose gemcitabine and hTERT-promoter-dependent conditionally replicative adenovirus enhances cytotoxicity through their crosstalk mechanisms in pancreatic cancer
Keywords: CRAD; Gemcitabine; Pancreatic cancer; CRAd; Telomerase; Virotherapy
Highly efficient and carcinoma-specific adenoviral replication restricted by the EGP-2 promoter
Keywords: CRAD; EpCAM; GA733-2; Tumor-specific promoter; CRAd; Human liver slices; Virotherapy
Targeting lung cancer using an infectivity enhanced CXCR4-CRAd
Keywords: CRAD; bp; base pairs; CMV; cytomegalovirus; CRAd; conditionally replicating adenovirus; MOI; multiplicity of infection; pfu; plaque-forming units; vp; viral particles; TSP; tumor-specific promoter; CXCR4 gene; Tumor-specific promoter; Transcriptional targeting;
Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion
Keywords: CRAD; Ad5; adenovirus serotype5; ANOVA; analysis of variance; CAR; coxsackie adenovirus receptor; CD; cytosine deaminase; CMV; cytomegalovirus; c.p.e. units; cytopathic effect units; CRAd; conditionally replicative adenovirus; CsCl; cesium chloride; [18F]-FHBG;